Gonorrhea: Symptoms, Diagnosis, Treatment & Urgent Action Steps
What Is Gonorrhea?
Neisseria gonorrhoeae – Gram-negative diplococcus, sexually transmitted. Infects columnar epithelium: urethra, endocervix, rectum, pharynx, conjunctiva. No first aid exists—requires prescription antibiotics.
Symptoms (Often Asymptomatic)
| Site | Men | Women |
| Urethral/Cervical | Purulent discharge, dysuria, urinary frequency, meatal erythema | Often asymptomatic; vaginal discharge, dysuria, intermenstrual bleeding, PID risk |
| Rectal | Discharge, pain, bleeding, tenesmus, pruritus | Same |
| Pharyngeal | Usually asymptomatic; sore throat, exudate | Same |
| Conjunctival | Purulent conjunctivitis, chemosis, lid edema (neonatal or autoinoculation) | Same |
Complications of Untreated Infection
- Women: PID (salpingitis) → tubal infertility, ectopic pregnancy, chronic pelvic pain, Fitz-Hugh-Curtis syndrome.
- Men: Epididymitis, prostatitis, urethral stricture, infertility.
- Disseminated (DGI): Arthritis-dermatitis syndrome (septic arthritis, pustules, tenosynovitis), endocarditis, meningitis.
- Neonatal: Ophthalmia neonatorum (blindness), sepsis, scalp abscess.
- HIV synergy: ↑ acquisition & transmission 3–5×.
Diagnosis
- NAAT (Nucleic Acid Amplification Test): Urine, swabs (urethral, endocervical, vaginal, rectal, pharyngeal). Gold standard: sensitivity >95%, specificity >99%.
- Culture: Required for antimicrobial susceptibility (increasing resistance).
- Gram stain: Rapid, but only for symptomatic urethral males (intracellular diplococci in PMNs).
Current CDC Treatment Guidelines (2021)
| Infection Site | Recommended Regimen | Alternative (if cephalosporin allergy) |
| Uncomplicated urogenital/rectal | Ceftriaxone 500 mg IM single dose (1 g if ≥150 kg) | Gentamicin 240 mg IM + Azithromycin 2 g PO (single doses) |
| Pharyngeal | Ceftriaxone 1 g IM single dose | Same as above |
| DGI | Ceftriaxone 1 g IV/IM q24h × 7 days | Consult ID specialist |
PLUS: Chlamydia co-treatment: Doxycycline 100 mg PO BID × 7 days (if not pregnant).
Critical Action Steps
- SEE A CLINICIAN IMMEDIATELY – no home treatment, no leftover antibiotics.
- Abstain from sex until 7 days after treatment completion AND partners treated.
- Partner notification & treatment (EPT where legal): All partners within 60 days.
- Test of cure: NAAT at 7–14 days if pharyngeal, symptoms persist, or pregnant.
- Full STI panel: HIV, syphilis, chlamydia, trichomonas, Hep B/C.
- Retest at 3 months (high reinfection rate).
Antimicrobial Resistance Alert
N. gonorrhoeae has developed resistance to sulfonamides, penicillins, tetracyclines, fluoroquinolones, and declining susceptibility to cefixime/azithromycin. Ceftriaxone is the last reliable monotherapy. Surveillance and stewardship are critical.
Gonorrhea - Related Articles